Overview

Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study

Status:
Completed
Trial end date:
2018-07-15
Target enrollment:
Participant gender:
Summary
This is a Phase 1, open-label, 2-cohort, food-effect, DDI, and formulation bridging study.
Phase:
Phase 1
Details
Lead Sponsor:
Theravance Biopharma
Treatments:
Hydroxyitraconazole
Itraconazole